Medical devices, healthcare technology and the business of care
COMPANY INTELLIGENCE

Coloplast Corp.

Explore this company’s associated devices, FDA decisions and regulatory history.

Clinical monitoring equipment, editorial photography

Coloplast Corp.

Regulatory records
8
Linked recall entries
0
Headquarters
Not reported
Brand website
coloplast.com
COMPANY INTELLIGENCE

What the linked records show

MedtechLedger currently links 8 FDA records to the applicant name Coloplast Corp.. The collection includes 2 510(k) clearances. 2 entries are PMA supplements. 4 entries are 30-day notices. These are records held by this publication, rather than a count of the company’s entire portfolio.

The dated entries run from Aug 14, 2025 to Oct 28, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.

Product code FHW appears in 5 of the 8 linked filings. The collection spans 4 FDA product codes and 2 original PMA application families. These figures describe the filings available here; they do not establish the company’s total device sales or market share.

The largest PMA family in this collection is P000006, with 5 linked entries. Follow the parent application and its dated supplements to distinguish the original device scope from later changes. 1 linked filing has a current plain-language explanation checked against the recorded FDA decision.

Applicant mailing address recorded by FDA: 1601 W. River Rd. N, Minneapolis, MN, 55411, US. Recorded on K263512, decision dated Oct 28, 2026.

Changes described in PMA records

P000006/S074: Titan Inflatable Penile Prosthesis

FDA’s recorded scope: to increase the amount of manufacturing cleanroom space by converting existing space into a new cleanroom, along with installing a deionized water system and clean dry air system in the cleanroom

Jul 21, 2026 · 30-Day Notice

P020003/S012: Torosa Saline Filled Testicular Prosthesis

FDA’s recorded scope: to increase the amount of manufacturing cleanroom space by converting existing space into a new cleanroom, along with installing a deionized water system and clean dry air system in the cleanroom

Jul 21, 2026 · 30-Day Notice

Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.

Devices & associated records

Product / regulatory recordCompanyPathwayDecision dateSource
Coloplast Corp.510(k) clearanceOct 28, 2026FDA
Coloplast Corp.510(k) clearanceOct 26, 2026FDA
Coloplast Corp.PMA supplementAug 13, 2026FDA
Coloplast Corp.PMA supplementJul 21, 2026FDA
Coloplast Corp.PMA supplementJul 21, 2026FDA
Coloplast Corp.PMA supplementJul 20, 2026FDA
Coloplast Corp.PMA supplementJun 2, 2026FDA
Coloplast Corp.PMA supplementAug 14, 2025FDA
Source information

Source updated Nov 9, 2026. Retrieved Nov 20, 2026.